BIO Survey Seeks To Uncover Inconsistencies In Review Divisions
This article was originally published in The Pink Sheet Daily
Executive Summary
The trade group will ask members to characterize their pre-clinical and clinical stage interactions with FDA in an effort to find potential efficiencies as well as inform upcoming legislation, including PDUFA VI.